Friday, 27 November 2020

Global Spirometry Market 2019-2023 | 10.3% CAGR Projection over the Next Five Years

 Overview:

The global Spirometry market is witnessing a significant rise in its revenues, mainly due to the rising occurrences of respiratory diseases such as asthma and COPD. Besides, the growing rate of diagnosis processes conducted for the detection of interstitial pulmonary fibrosis fosters the growth of the market. Moreover, the increasing exposure to risk factors and the ever-increasing population is driving a large share of the market.

Market Insights

According to the reports published by Market Research Future Reports, the global Spirometry Market is probable to exhibit a 10.03% CAGR from 2018 to 2023 and is also on the verge to reach USD 1,106.76 million by 2023. Such a humongous market growth can be attributed to the strident rise in the cases of chronic obstructive pulmonary disorders (COPD) and asthma.

Spirometry is considered as a basic test, which is conducted by clinicians to estimate the status of lungs. It is an essential test for diagnosing asthma, COPD, and other breathing disorders.  Thus, spirometers are used to carry out the tests.

Global Spirometry Market: Drivers & Trends

The factors such as emerging chronic respiratory diseases globally, increasing global aging population, and technological shifts in spirometer devices toward smartphone-based data connectivity and analysis are expected to drive the global spirometry market exponentially during the forecast period. With that, emerging economies with growing industrialization are also contributing to driving the market with opportunities for the future in substantial ways.

More stimulating factors such as government initiatives to restrain smoking habits of people, focus on breathing diseases, rising levels of air pollution, and expanding awareness towards the adoption of spirometers at homes are noticeably auguring the global spirometry market growth. Even awareness of reimbursement policies among the public and clinicians are also projecting to be the drivers for patients towards taking these tests. On the flip side, the high costs of spirometers may act as a restrictive factor against the market and hinder the global spirometry market growth.

Furthermore, the rising geriatric population is also anticipating being the factors for the increase in the demand for spirometers to analyze respiratory patterns. The need for spirometers is also probable in the rise due to a high number of surgeries in hospitals and clinics. These factors are tremendously driving the global spirometry market to rise high at a higher CAGR in the years to come.

Segmental Overview

According to the reports published by MRFR, the global spirometry market has been segmented by product, technology, application, and end-user.

By the mode of products, the market includes table-top spirometry, hand-held spirometry, and desktop (PC) spirometry.

By the mode of technology, the market has been segmented into volume measurement spirometry, peak flow meters (PFM), and flow measurement spirometry.

By the mode of application, the spirometry market is segmented into diagnostic and treatment monitoring.

Moreover, by the mode of end-users, the market includes research & academic institutes, diagnostic centers, hospitals & clinics, and home care.

Regional Outlook

Geographically, the market of spirometry has covered some main regions such as Americas, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA).

Among these, Asia Pacific is expected to register the highest CAGR for the market to proliferate during the forecast period. Growth of this market in the Asia Pacific region is driven mainly by the large population of the patient and a high prevalence of chronic respiratory diseases.

While North America has the largest market for spirometers owing to technological advancements, government regulations, rise in incidences of respiratory diseases, increasing healthcare expenditure, and improved healthcare infrastructure.

Key Players

In the end, here are the prominent players in the spirometry market, they are Carefusion Corporation (U.S.), NDD Medical Technologies, Inc. (U.S.), Nihon Kohden Corporation (Germany), MGC Diagnostics Corporation (U.S.), Vitalograph (U.K.), Schiller AG (Switzerland), COSMED srl (Italy), Hill-Rom Holdings, Inc. (U.S.), Midmark Corporation (U.S.), Smiths Medical Inc. (U.S.), and Koninklijke Philips N.V. (The Netherlands).

Read More @ https://www.marketresearchfuture.com/reports/spirometry-market-6539

Recent Industry News

Regular occurrence of dangerous diseases and increasing global population are the major driving factors for the market. Apart from these, negative factors like contamination and costly biological strain procedures will damage the growth of the market and hold the pace. Asia Pacific market will emerge as the fastest growing market and will contribute maximum to the global biological stains market.

NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:

Akash Anand

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com 

Biological Stains Market to Expand at a Healthy CAGR of 7.1%;

 Biological Stains Global Market Overview

Biological stains, as the name suggests, are a kind of dyeing mediums used in biological surveys. They are used to enhance the natural features of the tissues. Increasing disease count and identification will lead the global stains market to show nearly 07% annual growth in the forecast period.  Pharmaceuticals and biological research institutions will emerge as the largest users of this technology.

For Latest Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/6462 

With time, the diseases have proved to increase their dominance against the medicines and are emerging as more definite contenders. Biological stains help identify the changes in the structures, to keep a check on such developments and keep the pace parallel to them. Spreading awareness about the diseases and progress in treatment procedures is also helping the market to grow globally.

Authorities and other organisations are investing in research and developments programs to ensure and attain better health alternatives. Also, companies themselves should carry on such procedure on a personal basis for the sake of market and individual growth.

Market Segments of the Global Biological Stains Market

There are three segments to this market:

Types: Iodine, Congo red, methylene blue, safranin, fuchsin and others are some types of biological stains.

Uses: Biological stains are used for bacteriology, histology, DNA staining, gram staining and other identifications.

End-Users: Diagnostic labs, research institutes, pharma and biotech companies and others are the major consumers of the market.

Biological Stains Global Market Key Players

Some of the key players in the global biological stains market are Thermo Fisher Scientific Inc., Avantor, Becton, Dickinson and Company, Beckman Coulter, Inc., Merck KGaA, F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories, Inc, Water Corporation, bioMérieux SA


Biological Stains Global Market Regional Overview

Global biological stains market is observed based on four major markets, America, Europe, Asia Pacific and The Middle East & Africa.

America is the current leader of the market due to already well-established medical services, industrial infrastructure and rapid increase in the number of chronic diseases. Food testing practices are also playing a significant role in overall market growth.

Europe is the second-largest market globally. The market is facing this growth owing to reasons such as awareness among the masses, investments & demand for better health facilities and emphasis on research & development procedures. All of the above features are attracting the massive inflow of capital into the market and resulting in market growth.

The Asia Pacific is at the third place. As per future projections, this market is going to show the highest annual growth rate and will emerge as the fastest-growing market. Large population count, an increasing number of patients, improving healthcare services & its demands and investments for rapid research & development are considered as the main reasons for the healthy growth of this market.

The Middle East & African region are growing at slow speeds and are going to remain the same for whole projected periods due to lagging growth meter and lack of awareness.

Read Complete Report @https://www.marketresearchfuture.com/reports/biological-stains-market-6462

Recent Industry News

Regular occurrence of dangerous diseases and increasing global population are the major driving factors for the market. Apart from these, negative factors like contamination and costly biological strain procedures will damage the growth of the market and hold the pace. Asia Pacific market will emerge as the fastest growing market and will contribute maximum to the global biological stains market.

NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:

Akash Anand

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com 

Veterinary Pain Management Market -Worldwide Trends, Regional Forecast, News and Forecast

Market Highlights:
Veterinary Pain Management Market Size is growing rapidly and pervasively mainly due to the spreading awareness towards animal care. People are generally compassionate towards their pets, and they are increasingly becoming aware of animal physiology and psychology and the pain they go through during sickness, injuries, recoveries and after effects of the diseases. Besides, factors such as the increasing number of pet owners and the strengthening bond between owners and their animal companions escalate the market on the global heights.

Get Sample PDF @https://www.marketresearchfuture.com/sample_request/5961

Global Veterinary Pain Management Market is expected to register a CAGR of 6.46% during the assessment period of 2020 to 2027, to reach USD 4,582.8 Million by 2027.

Additional factors substantiating the market growth include the rising per capita income that is leading to increasing the pet adoptions and the trend of nuclear families. Increased awareness concerning animal cruelty is influencing people’s ideologies and knowledge about animals.

Moreover, developments in animal health medicines and vaccines, along with the increased medical treatments are fostering the market growth of veterinary pain management market. Increased R&D expenditure to bring innovations in the products, and development of better and effective veterinary pharmaceuticals and vaccines, etc. are contributing to the market growth.

Improving economic conditions worldwide foster market growth, enabling access to the quality of life, increasing consumers’ buying power, and availing cost-effective veterinary healthcare.

On the other hand, factors such as the lack of awareness and knowledge pertaining to the animal well-being and the rising cost of pet care, etc. are expected to impede the market growth. Also, unavailability of skilled doctors is a major restraint the market is confronting with.  Nevertheless, technological advancement, increasing number of ambulatory services coupled with the government and public organizations initiatives like PETA, working towards animal rights and liberation are expected to support market growth.

Veterinary Pain Management Market   - Segmentations
MRFR has segmented the analysis into seven key dynamics for better understanding: -

By Drug Type: Nonsteroidal Anti-Inflammatory Drugs, Opioids, Local Anesthetics, Α2-Adrenergic Agonists, Muscle Relaxants, Sedatives, and Corticosteroids among others.

By Devices: Laser Therapy Devices and Electromagnetic Therapy Devices among others.

By Route of Administration: Oral, Parenteral, and Topical among others. 

By Animal Type: Companion Animals, Livestock, Research Animals, Aquatic Animals, Zoo Animals, and Exotic Animals among others.

By Application: Joint Pain, Postoperative Pain, and Cancer among others.

By End-user: Veterinary Hospitals & Clinics, Research Institutes & Universities, and Laboratories among others.                                                                                                                  

By Regions:  Europe, North America, APAC and the Rest-of-the-World.

Veterinary Pain Management Market   - Geographical Analysis
The North American region accounts for the leading market for veterinary pain management majorly due to the availability of a range of animal care products, emphasis on animal health, and stringent government regulations.  Also, technological innovations in the field of veterinary surgical instruments are acting as a tailwind pushing up the market growth in the region. 

Additional factors such as growing insurance coverage schemes are expected to push the growth of the veterinary pain management market in the region. Moreover, the increasing number of pets and a large patients’ pool, contribute to the growth of the regional market, demanding various treatment procedures and surgeries.

Countries such as Canada and the US are focusing on exporting surgical equipment and surgical suturing material across the world, which, in turn, is increasing the size of the market in this region. Besides, the growing number of veterinary hospitals fuel market growth.

The Veterinary Pain Management Market in the European region stands the second position in terms of the market size, owing to the increasing pet ownership fuelled by the tax benefits granted by the government.  Increase in animal diseases has led to an increasing number of surgeries and veterinary healthcare organizations. European countries like Germany, France, and the U.K, backed by the significant expenditures in the field of manufacturing of veterinary medical and surgical devices, majorly contributes to the growth of the regional market.

The Asia Pacific region is emerging as a promising market for companion veterinary pain management. China among other APAC dominates the regional market whereas, India accounts for the fastest growing market, followed by Australia and Japan.  Factors such as the presence of a large patient’s pool, increasing awareness towards animal health, and the improving economy are few of the driving forces pushing up the market in the region.

Veterinary Pain Management Market   - Competitive Landscape
The fiercely competitive veterinary pain management market appears to be fragmented due to many players forming a competitive landscape. Mergers & acquisitions, innovations, and Brand reinforcement remain the popular trends for the market players. Acquisitions of local manufactures by multinational companies are changing the market structure, increasing the profit of the company by reducing the competition significantly.

Key Players:
Some of the players leading the market include Zoetis, Boehringer Ingelheim, Chanelle, Ceva Santé Animale, Dechra Pharmaceuticals, Norbrook Laboratories, Merck Animal Health, Elanco, Assisi Animal Health, Bayer, and Vetoquinol.

Industry/ Innovation/ Related News:

November 08, 2018 – Vetoquinol USA, a world-class developer of veterinarian-approved formulas for large animal healthcare products, announced the launch of its rebranded product line - EQUISTRO®. The rebranding includes new packaging for products and others. All EQUISTRO products are now available in veterinary clinics and in retail stores that sell feed, farm supplies, horse tack, and equine products. The rebranding strategy helps to expand the products available for performance horses through Vetoquinol.

Browse Complete Report @ https://www.marketresearchfuture.com/reports/veterinary-pain-management-market-5961

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

 MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

 Contact:

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

Latest Research On Acupuncture Market (2018-2023) | trends, Global Analysis and Forecast

 Acupuncture is an alternative medicine approach which uses needles that are inserted into the skin at acupuncture points to treat several diseases. Acupuncture has notably emerged from China as a component of their health care system. The overall working of acupuncture is based on the foundation that there are patterns of energy flow, Qi, through the body which are important for health, and acupuncture corrects the imbalances of flow at identifiable points close to the skin. The market is expected to expand with a CAGR of 14.50 percent while earning revenues worth USD 55323.8 million in the duration of the forecast period from 2018 to 2023.

Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/6139

The market growth is fuelled by factors such as the growing incidence of gynecological disorders such as menstrual issues, PMS, PCOS, pregnancy complaints, menopause, infertility, and chronic pain disorders which are encouraging the development of the acupuncture market globally. Additionally, the rising occurrence of chronic diseases such as fibromyalgia and migraines which lead to health complications such as insomnia, body pain, and psychological illness will boost the progress of the acupuncture market globally. The escalating demand for non-invasive and painless acupuncture has led to an increase in the level of advancements in acupuncture therapy. The advent of technically advanced acupuncture treatments such as the usage of laser devices and electro acupuncture is projected to improve the development of the acupuncture market internationally for the duration of the forecast period. Moreover, many notable competitors are getting involved in the development and manufacturing of laser and electro acupuncture devices.

Increasing health complications in the elderly population such as sleep disturbances, body pain, and emotional disorders have also powered the development of the market. The mounting geriatric population worldwide is anticipated to influence the acupuncture market in the forecast period. The intensifying demand for alternative and complementary medicine like acupuncture has enhanced the funding scenario for the market which can be a vast opportunity for the expansion of the market through the forecast period. The funding from market contenders and new entrants in the market is likely to add to the market’s growth in the forecast period.

Segmental Analysis

The acupuncture market is segmented on the basis of application, end user, product & services. The segmentation of the market on the basis of product & services comprises of services and products. The service segment is further segmented into Japanese acupuncture, traditional Chinese medicine, auricular, Korean hand acupuncture, and scalp acupuncture, moxibustion, non-insertion acupuncture, cupping, and others. The product segment is additionally segmented into suction cups, needles, rod lasers, laser needle, and laser pens, electro-acupuncture device, and others. The needles are additionally sub segmented into modern needles and traditional needles. The service segment controls the acupuncture market by product & services due to the growing preference given to traditional acupuncture therapies. By application, the market is segmented into gynecological disorders, pain syndrome illnesses, psychological illnesses, and others. Pain syndrome illnesses controls the major market share of 33.5 percent over the forecast period, and it is also projected to develop at a CAGR of 14.04 percent through the forecast period. The end user segment of the market is segmented into hospitals & specialty clinics, wellness center, and research & academic institutes. Wellness Centre will possibly control the global acupuncture market due to a huge number of wellness center involved in acupuncture therapies and the rising preference for acupuncture as alternative medicine.

 

Detailed Regional Analysis 

The regional analysis of the market observes that the European region is expected to control the prime market share in the acupuncture market globally and is projected to develop at a CAGR of 13.53 percent during the forecast period. The market development is accredited to the intensifying occurrences of chronic diseases and growing preference for acupuncture therapies amongst the European population. Furthermore, the existence of major market contenders significantly adds to the market growth in the region. Additionally, the escalating insurance coverage in nations like France, Austria, Spain, and others, by other private companies will offer a promising backdrop for the market growth in the European region.

The Asia Pacific region is likely to be the most swiftly increasing region in the acupuncture market globally and is anticipated to develop at a CAGR of 15.02 percent for the duration of the assessment period. The growth of the Asia Pacific acupuncture market is credited to the existence of nations such as Korea, China, and Japan which has a high adoption rate for acupuncture therapies. Additionally, the growing number of companies manufacturing the acupuncture products and the rising prevalence of chronic diseases is powering the market growth in this region.

Competitive Analysis

Several competitors are functioning in the acupuncture market globally. Many organizations, particularly in the European and Asia Pacific regions, have their manufacturing units, while some organizations are also involved in import from other regions. As the Asia Pacific is one of the most rapidly rising markets, firms are grasping the chances that are available and are keenly expanding their units in this region. However, the acupuncture market is presently controlled by a few players. The major competitors outlined in the report comprises of Zepter International, schwa-medico GmbH, MKW Lasersystem GmbH, Wuxi Jiajian Medical Instruments Co., Ltd, Cymedics GmbH & Co. KG, 3B Scientific GmbH, Kanson, SEIRIN Corporation, Asia med GmbH, Qingdao Great Fortune Co. Ltd, and AcuMedic Ltd.

 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

 MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

key Trends On Diagnostic Electrocardiograph (ECG) Market Size by Top Companies and Demand

 Market Analysis 


The global diagnostic electrocardiograph (ECG) market is likely to touch USD 10,487.24 million at a 6.72% CAGR between 2019- 2025, as per the recent report by Market Research Future (MRFR). Diagnostic electrocardiograph, simply put, is a test that is utilized to detect electrical signals which the heart produces each time it beats. Smart ECG monitors, Holter monitors, event monitors, mobile cardiac telemetry devices, implantable loop recorders, stress ECG devices, and resting ECG devices are the different types of the diagnostic electrocardiograph. 


Get Free PDF @https://www.marketresearchfuture.com/sample_request/8787


Various factors are adding to the global diagnostic electrocardiograph market growth. Such factors, according to the new MRFR report, include increasing expenditure by market players in research and development to create novel ECG devices, technological advances in wearable devices and wireless monitoring, and an increase in the rate of lifestyle diseases. Additional factors adding market growth include the developing healthcare infrastructure, increasing geriatric population, and rising cases of cardiovascular diseases. 


On the contrary, irregular reimbursement policies, uncertainty in economic circumstances and market saturation, and scarcity of skilled professionals are factors that may limit the diagnostic electrocardiograph market growth over the forecast period


Market Segmentation


The MRFR report offers an inclusive segmental analysis of the global diagnostic electrocardiograph market report based on end user, product type, and lead type. 


By product type, the diagnostic electrocardiograph market is segmented into smart ECG monitors, Holter monitors, event monitors, mobile cardiac telemetry devices, implantable loop recorders, stress ECG devices, and resting ECG devices. Of these, the resting ECG devices segment will lead the market over the forecast period for its increasing use in hospitals worldwide. 


By lead type, the diagnostic electrocardiograph market is segmented into single-lead ECG devices, 6-lead ECG devices, 3-lead ECG devices, 5-lead ECG devices, and 12-lead ECG devices. Of these, the 3-lead ECG devices segment will dominate the market over the forecast period for its wide applications in various cardiac diagnostic tests. 


By end user, the diagnostic electrocardiograph market is ambulatory surgical centers, hospitals and clinics, and others. Of these, the ambulatory surgical centers segment will have a major share in the market over the forecast period for its ample recognition in developing countries. 


Regional Analysis 


Based on the region, the global diagnostic electrocardiograph market report covers the recent trends and growth opportunities across the Americas, Europe, the Asia Pacific (APAC), and the Middle East and Africa (MEA). Of these, the Americas will have lions share in the market over the forecast period. Surging demand for medical devices coupled with rising cases of cardiovascular diseases like arrhythmia and stroke, are adding to the growth of the market in the region. 


The global diagnostic electrocardiograph market in Europe is predicted to hold the second-largest share over the forecast period. Rising acceptance of new diagnostic products and increasing geriatric population are adding to the growth of the market in the region. 


The global diagnostic electrocardiograph market in the APAC region is predicted to grow at a fast pace over the forecast period. Rising prevalence of heart diseases like stroke and increasing per capita disposable income are the factors that are adding to the market growth in the region. 


The global diagnostic electrocardiograph market in the MEA is predicted to have steady growth over the forecast period. The increasing burden of cardiac diseases and gradually developing healthcare infrastructure are factors that are adding to the market growth in the region. 


Key Players


Eminent players profiled in the global diagnostic electrocardiograph market report include VectraCor, Inc. (US), Innomed Medical Inc. (Hungary), Norav Medical (US), Cardioline SpA (Italy), Edan Instruments, Inc. (China), BTL (US), Fukuda Denshi (Japan), BPL Medical Technologies (India), ACS Diagnostics (US), Schiller (Switzerland), Shenzhen Mindray Bio-Medical Electronics Co., Ltd (China), Hillrom Services, Inc. (US), Nihon Kohden Corporation (Japan), Koninklijke Philips N.V. (Netherlands), and General Electric Company (US). 


Read More@ https://www.marketresearchfuture.com/reports/diagnostic-electrocardiograph-market-8787


About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com 


NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

News: Medication management Market Trends. global Size & share by 2023

 Medication management is an approach to understand the purpose of the medications and its timely administration in the correct manner. Adherence to a medication regimen is vital especially for geriatrics and patients with multiple chronic conditions. Failing to comply with a medication regimen is often cited as a paramount reason why patients are readmitted in the hospital following discharge. 

Free Sample PDF Avvailable Here !! https://www.marketresearchfuture.com/sample_request/7187

In such scenarios, medication management services have been proving to be effective providing medication reconciliation, medication therapy management, patient/family education on medications and medication set-up simulations for the patient. Many home care providers have also started to make in-home medication management a core component of their operations.

For many aging populaces, relinquishing medication management services to a third party is one of the easier options. And it’s becoming a market differentiator among seniors looking for reliable, competent and service-minded companies to manage one of their most critical medical issues. 

Also, for the patients suffering from chronic illnesses who usually have to administer and monitor 10-12 medications per day, resorting to smart medication management systems which promote their wellbeing becomes useful. 

As a result, the uptake of medication management is growing which, in turn, is increasing the size of the global medication management market. Moreover, the recent trend of prescription medicine is escalating the market on the global platform. 

Considering the colossal growth, the market perceives currently; Market Research Future (MRFR), in its recently published study report asserts that the global medication management market will grow exponentially by 2023, registering approximately 13.4% CAGR throughout the forecast period (2018 – 2023).

Additional factors helping the market to boost further are the ever-increasing population, geriatric populaces, and increased occurrence of chronic diseases which are growing the need for the medication management solutions.

Advancements in IT technology and increasing uptake of healthcare IT for efficient management are expected to increase the size of the market. Furthermore, the rising government supports and the need for curtail healthcare costs without compromising the quality of care are some of the factors impacting the growth of the market, positively. 

On the other hand, factors such as high software implementation and service maintenance costs are impeding the growth of the market. Nevertheless, the advantages that medication management offers allowing the consolidation of all expenses which consequently saves the further cost of patient care is expected to act as a major tailwind supporting the growth of the market. 

 for care management solutions.  Moreover, the increasing healthcare expenditures are escalating the market on the global platform, increasing the need to curtail cost without compromising the quality of care.

 

Global Medication Management Market – Segmentation

For ease of understanding, the MRFR analysis has been segmented into five key dynamics: -

By Systems Computerized Physician Order Entry Systems, Administration Software, Clinical Decision Support Systems, Inventory Management Systems, Automated Dispensing Systems, and Assurance Systems among others. 

By Services Point-of-Care Verification Services and Adverse Drug Effects (ADE) Surveillance Services among others. 

By Mode of Delivery Web-based Solutions, On-premise Solutions, and Cloud-based Solutions among others.

By End-user : Hospitals and Pharmacies among others.

By Regions North America, Europe, Asia Pacific, and the Rest-of-the-World.

 

Medication Management Market – Regional Analysis

The North American region, heading with the presence of numerous key players is estimated to retain its dominance over the global medication management market. This region accounts for the best of the medical facilities around the world, and so is the higher rate of patients which along with the robust economy and high healthcare expenditure drive the medication management market in the region. 

Furthermore, the increasing number of polypharmacy, hospitals, and ambulatory centers alongside the well-developed technology drive the market growth in the region, meeting the higher demand of a vast patient population. 

The medication management market in the European region accounts for the next-largest market share, globally. Factors allowing the market to substantiate include the increasing demand for management software & platforms, strong government support, and availability of funds among others. Western European region backed by the presence of well-developed economies such as the U.K., Germany, and France holds a significant share in the regional market. Indeed, the resurging economy is playing a vital role in the growth of the market, making the high cost of medication affordable and increasing per capita income in this region. 

The Asia Pacific medication management market has emerged as a profitable market, globally. Factors such as the rapidly proliferating healthcare sector that is led by the improving economy, the increasing number of players, increasing government’s support and foreign investments, and vast technological advancements are impacting the regional market, positively. Additionally, the growing number of patients suffering from chronic diseases alongside the increasing per capita healthcare expenditure provide impetus to the growth of the market.

The Asia Pacific together accounts for over 41% of the global population, and most of the APAC countries are in the developing phase which leads to providing immense opportunities for the market players. Larger countries such as China and India backed by the densely populated area are considered as the biggest market for the Medication Management products in the region.

 

Global Medication Management Market – Competitive Analysis 

The medication management market appears fiercely competitive with the presence of several large and small players. The key strategies traced from the analysis of recent market developments include agreement & partnership, product launch, acquisition, and expansion.  International players who are increasingly expanding their footprint in the developing economy, making it difficult for regional players to compete with them.

Major Players:

Key players leading the global medication management market include Mckesson Corporation, Allscripts Healthcare 0Electric Company, Medical Information Technology, Inc., Optum Inc., Omnicell, Inc., QuadraMed Affinity Corporation, and Siemens Ltd among others.

Industry, Innovation & Related News 

March 06, 2019 ---- BrightSpring Health Services (the US) a leading provider of comprehensive home and community-based health services announced its merge with the PharMerica (the US), a pharmacy powerhouse to position itself to lead the medication management, potentially.

BrightSpring hopes to effectively address medication needs while also providing caregiver services by providing its clients the right medications suiting their ailments in a timely and reliable manner and then helping to make sure they do so consistently. 

The merging deal will give BrightSpring a footprint with difficult-to-top proximity to the patients and clients it serves including behavioral health and specialty populations, along with older adults. KKR an affiliate of Walgreens Boots Alliance Inc. and a global investment firm had recently acquired BrightSpring (formerly ResCare) as part of the deal. 

Read Complete Report With Toc @ https://www.marketresearchfuture.com/reports/medication-management-market-7187


About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com 

 

Healthcare Contract Manufacturing Market Size, Key Insights Based on Applications, Material and Regional Demand 2020

 Global Healthcare Contract Manufacturing Market Research Report: Information by Type (Sterile and Non-Sterile), Service Type (Pharmaceutical Contract Manufacturing and Medical Device Contract Manufacturing), Industry (Pharmaceutical Industry, Medical Device Industry and Biopharmaceutical Industry) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) - Forecast till 2023

Market Scope

The global healthcare CMO market had touched the valuation of USD 129.91 billion in 2016, estimates Market Research Future (MRFR). It is projected to attain a CAGR of 9.86% during the forecast period (2017–2023), Growth Drivers and Top Restraints 

Growth Factors and Key Challenges 

The data analysts opine that the worldwide healthcare contract manufacturing market is expanding at a moderate but healthy rate. The chief factors backing the market growth include competition among companies with respect to the production and trade that favor CMO and the patent protection expiration of significant medical devices as well as drugs. Also, with both the contract manufacturers and clients reaping benefits and the agile form of manufacturing boosts market growth significantly. 

Read More @ https://www.marketresearchfuture.com/sample_request/5637 

Developing regions like Asia Pacific, Latin America and Middle East and Africa are experiencing potent growth of the biotechnology and pharmaceutical sectors. Several government bodies within these regions lend strong support in the form of numerous programs, conferences, initiatives as well as funding. The rapidly expanding pharmaceutical and biotechnology sectors lead to rise in demographic and economic growth along with surge in healthcare expenditures. On top of this, enhancement in the public-private healthcare funding has led to market growth in recent years. Therefore, developing areas across the globe are presumed to offer numerous growth opportunities to the healthcare CMO market in the following years.

The healthcare contract manufacturing market’s growth has been striking in the last few years owing to the numerous advantages offered by several international contract manufacturing companies. These companies offer a host of services to the pharmaceutical, medical device and biopharmaceutical companies. The pharmaceutical and biopharmaceutical companies enjoy numerous services by the CMO, whether it is the production of small amounts of materials for research and development (R&D) activities or huge funding for clinical study and commercialization.

Market Segmentation 

The worldwide healthcare contract manufacturing market has been segmented on the basis of type, service type, and industry.

The type-wise segments are sterile and non-sterile. Non-sterile is believed to have the fastest growth rate of 10.0% from 2017 to 2023.

Depending on the service type, the market includes pharmaceutical contract manufacturing services, medical device contract manufacturing services.

The industries mentioned in the report are pharmaceutical, medical device, and biopharmaceutical.

Regional Analysis 

Europe, Middle East and Africa, Asia Pacific and the Americas are the key markets for healthcare contract manufacturing. 

The Americas has been identified as the leading healthcare contract manufacturing market, backed by high investment in healthcare and the presence of strong economy. The rising focus of research institutions on advancement of technology also benefits the regional market. Data experts note the rising focus of the contract manufacturers on the upgradation of their factories as well as manufacturing capabilities. As a result of cost-efficient models and advanced manufacturing units, the healthcare contract manufacturing market in the region is projected to expand considerably in the near future. 

Europe is the second-most profitable market for healthcare contract manufacturing owing to the growing support from the governments and the high spending on healthcare. The Organization for Economic Co-operation and Development (OECD) reports that in 2014, the healthcare expenditure in Germany was around EUR 321 billion whereas France had the second highest healthcare expenditure of EUR 237 billion that year.

Growing at the fastest rate, Asia Pacific seems to possess lot of potential due to the high number of developing nations like India and China. These emerging economies are stimulating the growth of the healthcare contract manufacturing market, with the presence of highly developed healthcare infrastructure and the consistently advancing healthcare technology. 

Middle East & Africa, with the least market share, lags behind due to less availability of medical facilities and poor development of the healthcare sector. But, countries like Kuwait and Qatar are striving to develop their medical facilities, which will have a positive impact on the overall regional market in the subsequent years.

Key Vendors

The key vendors identified by MRFR include Lonza Ag, Catalant, Patheon, Mylan, Teva Pharmaceutical Industries, Benchmark Electronics, Vetter Pharma International, AbbVie, Boehringer Ingelheim, Aesica Pharmaceuticals, Grifols International, S.A, Hamilton Company, Sanmina Corporation, Flex Ltd, Forefront Medical Technologies, Evonik Industries to name a few.

Latest Developments 

April 2019

Catalent will be acquiring Paragon Bio-services, a contract manufacturing organization with focus on viral vectors that are used in gene therapies, for the cost of USD 1.2 billion.

Read More @ https://www.marketresearchfuture.com/reports/healthcare-contract-manufacturing-market-5637 ​​​​​​​

NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:        

Akash Anand             

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com